These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 19175400)

  • 1. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
    Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A
    Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
    Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
    Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
    Moore SA; Muñana KR; Papich MG; Nettifee-Osborne J
    Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
    Coppola G; Mangano S; Tortorella G; Pelliccia A; Fels A; Romano A; Nardello R; Habetswallner F; Licciardi F; Operto FF; Pascotto A
    Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
    Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.